Mark Miller

Mark Miller is a highly experienced professional in health economics and market access, currently leading HEMA activities at Lumicell, which focuses on cancer detection solutions. Mark's previous roles include overseeing market access initiatives at Sonablate Corp, where a High Intensity Focused Ultrasound device is utilized for prostate disease, and serving as Chief Operating Officer at ViFiVE Inc., a startup in mobility AI healthcare. Mark has advised organizations such as Nurx, providing strategic guidance on access solutions, and worked as a venture partner at MBX Capital, supporting healthcare startups. Additional experience includes executive roles at Cosmo Pharmaceuticals, YGEIA Group, and Marina Del Rey Hospital, as well as significant positions at Allergan, where Mark developed market access strategies for a diverse portfolio. Mark holds a Bachelor of Science in Behavioral Sciences from the United States Military Academy at West Point and an MBA in Management from Pepperdine University.